Short The current market price of the stock at 5,490, is significantly inflated compared to its estimated intrinsic value of approximately 1,555, based on the current EPS of 14.43 and the P/E ratio of 107.84. This stark discrepancy suggests that the stock is trading well above its fundamental worth, implying that it may be overvalued.
Such a valuation could be driven by overly optimistic market sentiment or speculative buying, especially given that we are in an environment where market prices have reached unprecedented levels not seen in recent history. If the market corrects, as many analysts anticipate, the stock price could face a significant downward adjustment, leading to what some are predicting could be a bloodbath in the near future.
This scenario highlights the disconnect between the stock’s price and its true intrinsic value, suggesting that the market may be overpricing future growth prospects, or investors are too focused on short-term factors rather than the company’s actual earnings performance and financial health.
